Ringgold doctor sued under false claims act for administering unneeded drug - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
August 14, 2019 Newswires
Share
Share
Post
Email

Ringgold doctor sued under false claims act for administering unneeded drug

Chattanooga Times Free Press (TN)

Aug. 13--A physician who relocated from Hixson to North Georgia over a previous medical licensing dispute has been sued for what federal attorneys charge are improper Medicare claims at Preventative Medicine Anti-Aging & Chelation, Inc., which operates in Ringgold and Atlanta.

In a false claims suit filed against Dr. Robert C. Burkich, the Department of Justice claims Burkich and his colleagues improperly billed Medicare for more than $3 million of chelation treatment even though Medicare pays for the treatment only in the rare instances of lead poisoning. Under the false claims act, Burkich's practice could be liable for treble damages, or more than $9 million. The lawsuit asks the curt to impose civil penalties of $5,000 to $11,000 for each fale claims the medical practice submitted to Medicare.

In a 71-page complaint filed in Atlanta, U.S. Attorney Byung J. Pak alleges that Burkish and other health care providers in his practice intravenously administered the chelation drug edetate calcium disodium (EDTA) to Medicare beneficiaries who were not suffering from lead poisoning as required for such Medicare-paid treatments.

"Since at least 2012, (Burkich an his colleagues) have knowingly presented claims to the United States in the form of bills for cherlation services to patients that do not meet the specified requirements of the American Medical Association," Pak said. "When healthcare providers falsely certify that the services they provide to patients are medically necessary, they deplete the resources available to Medicare beneficiaries that are actually in need of care."

Dr. Burkich admitted that he left Tennessee and relocated to Georgia because he felt that Tennessee restricted the use of EDTA to patients suffering from lead poisoning. He said he believed Georgia allowed EDTA to be utilized as an experimental treatment for a variety of conditions.

The Justice Department, acting on a petition by Dr. Stephen Barrett who filed the false claims act against Burkich to qualify for some of the penalties allowed under the law for Medicare fraud, claims that Burkich advertised and administered EDTA as a treatment for a variety of conditions other than lead poisoning, such as heart disease, fatigue and osteoarthritis. But the regulators said that Medicare does not cover EDTA chelation therapy for alternative or experimental uses.

Chelatin therapy is performed by administering the drug EDTA that binds to metallic particles or ions in the body and causes them to be excreted with urine. The EDTA drug is FDA-approved only for treating lead poisoning, but the lawsuit claims "the vast majority of practitioners who administer intravenous chelation in their offices are using it to purportedly treat cardiovascular disease, which Medicare will not pay. To get payment for the services, "chelationists "must use creative coding that attempts to disguise what they do," the suit claims.

Public health officials reported that in 2012 and 2013 there were no reported blood tests showing lead poisoning among patients 65 and older in the counties served by Dr. Burkich, even though Burkich and his colleagues billed Medicare for such treatment to 344 patients, according to the federal lawsuit filed last week.

The complaints were filed after an investigation by the Inspector General of Investigations in the region, Thomas W. South.

"We will not allow greed to impede beneficiaries' access to necessary, quality health services," Derrick L. Jackson, special agent in charge for the Office of Inspector General of the U.S. Department of Health and Human Services, said in a statement. "Our agents, working closely with our law enforcement partners, will continue to protect taxpayer dollars and vulnerable recipients of government healthcare programs."

No one returned calls Tuesday from the Preventative Medicine Anti-Aging & Chelation, Inc.,

The false claims lawsuit against Burkich is not the first time the medical doctor has been in trouble with the law. In 2001, a Grand Jury in Chattanooga returned indictments against Burkich for his role in starting a dinner club called The Website which allegedly falsified the theft of automobiles to claim they were stolen for insurance purposes.

He had to perform 150 hours of community service and pay a $4,000 fine plus a $100 assessment.

Burkich lost his Georgia medical license in 2003 and his Tennessee medical license the following year. Tennessee reinstated his medical license in 2008, and Georgia restored his license in 2011.

Contact Dave Flessner dflessner@timesfreepress.com or at 757-6340.

___

(c)2019 the Chattanooga Times/Free Press (Chattanooga, Tenn.)

Visit the Chattanooga Times/Free Press (Chattanooga, Tenn.) at www.timesfreepress.com

Distributed by Tribune Content Agency, LLC.

Older

Trump opponents turn up heat as NH rally nears

Newer

Insurance Agent Accused Of Scamming Elderly Arrested In NC

Advisor News

  • The 6X Formula for leveraging content marketing with AI
  • When a home becomes difficult to insure, the plan changes
  • The inheritance gap: Helping clients plan for money that hasn’t arrived
  • After the midterms: Addressing your clients’ tax concerns
  • Berkeley arts tax heads toward passage while public bank measure looks likely to fail
More Advisor News

Annuity News

  • DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
  • John Hancock launches new fixed indexed annuity suite
  • Annuities to play a larger role in workplace retirement plans
  • FHLBank Pittsburgh Announces Results in 2026 Board Election
  • Regulators advance shorter, streamlined annuity buyers guide
More Annuity News

Health/Employee Benefits News

  • High costs limit rural Nebraskans’ access to health care
  • Medicare is already reading your 2026 tax return
  • LUJAN, WARNOCK LEAD BROAD COALITION OF SENATORS TO PUSH SENATE LEADERSHIP TO DELAY REPUBLICAN MEDICAID CUTS OVER CONCERNS ABOUT COVERAGE LOSS
  • WARNOCK LEADS BROAD COALITION OF SENATORS TO PUSH SENATE LEADERSHIP TO DELAY REPUBLICAN MEDICAID CUTS OVER CONCERNS ABOUT COVERAGE LOSS
  • What happens when Medicare coverage begins
More Health/Employee Benefits News

Life Insurance News

  • Military Briefs: November 12-18
  • Security Benefit Series B Preferred Stock Dividend Rate Resets to 10.286%
  • FHLBank Pittsburgh Announces Results in 2026 Board Election
  • New Jackson Study Finds the "Sandwich Generation" Squeeze Comes from More Than Two Sides and It’s Quietly Draining Retirement Savings
  • Samsung Fire & Marine Insurance to Acquire Outstanding Stake in Canopius with KKR and KIC
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.